Neuropathy in multiple sclerosis patients treated with teriflunomide

OBJECTIVE: Teriflunomide is an oral medication approved for the treatment of patients with multiple sclerosis. The primary effect of teriflunomide is to reduce de novo pyrimidine synthesis by inhibiting mitochondrial dihydroorotate dehydrogenase, thereby causing cell-cycle arrest. We aimed to invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilic, Ahmet Kasim, Suzan, Aysegul Akkan, Bulut, Anil, Sahbaz, Gulhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427169/
https://www.ncbi.nlm.nih.gov/pubmed/37585981
http://dx.doi.org/10.1590/1806-9282.20221514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427169/
https://www.ncbi.nlm.nih.gov/pubmed/37585981
http://dx.doi.org/10.1590/1806-9282.20221514

Ejemplares similares